COMMUNIQUÉS West-GlobeNewswire

Devonian annonce l’octroi d’options

29/06/2018 - 14:45

QUÉBEC, 29 juin 2018 (GLOBE NEWSWIRE) -- Groupe Santé Devonian Inc. (« Devonian » ou la « Société ») (TSX CROISSANCE:GSD) annonce que le conseil d'administration a approuvé l'octroi d'options (les «options») pour [...]

Emisphere Development Update

29/06/2018 - 14:30

ROSELAND, N.J., June 29, 2018 (GLOBE NEWSWIRE) -- Novo Nordisk announced yesterday the completion and results of the phase 3a trial, PIONEER 3, with oral semaglutide, a once-daily oral formulation of the long-acting GLP [...]

Alder BioPharmaceuticals® Presents New Six-Month Data for Eptinezumab Demonstrating Improvement in Efficacy in PROMISE 2 Phase 3 Trial for Chronic Migraine

29/06/2018 - 14:30

- Data presented today at the American Headache Society (AHS) Annual Scientific Meeting demonstrate 43% of patients receiving 300 mg of eptinezumab achieved a 75% or greater reduction of monthly migraine days - 1 in 5 [...]

Alder BioPharmaceuticals® Presents New One-Year Data for Eptinezumab from PROMISE 1 Phase 3 Trial Demonstrating Long-Term Efficacy in Episodic Migraine

29/06/2018 - 14:30

- Data presented today at the American Headache Society (AHS) Annual Scientific Meeting demonstrate eptinezumab’s robust efficacy is further improved at one year following third and fourth quarterly infusions - [...]

AzurRx BioPharma Announces Successful Phase IIa Trial of MS1819-SD in Exocrine Pancreatic Insufficiency

29/06/2018 - 14:30

NEW YORK, June 29, 2018 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (NASDAQ:AZRX) (“AzurRx” or the “Company”), a company specializing in the development of non-systemic, recombinant therapies for gastrointestinal [...]

Tauriga Sciences Inc. Completes Initial Purchase Order with Blink Charging Co. for 4 Level II Electric Vehicle Pedestal Charging Units

29/06/2018 - 14:25

NEW YORK, NY, June 29, 2018 (GLOBE NEWSWIRE) -- Tauriga Sciences, Inc. (OTC PINK: TAUG) ("Tauriga" or the "Company"), engaged in building its business through the development, distribution, and licensing of proprietary [...]

Canada House Wellness Group Announces Issuance of Stock Options

29/06/2018 - 14:23

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, June 29, 2018 (GLOBE NEWSWIRE) -- Canada House Wellness Group Inc. (CSE:CHV) (“ Canada House ” or the “ Company ”) is pleased [...]

Novartis receives positive CHMP opinion for Kymriah® for treating two aggressive blood cancers, marking important medical advance for patients in Europe

29/06/2018 - 14:11

First CHMP opinion for a CAR-T cell therapy in two distinct indications - DLBCL in adults and B-cell ALL in children Marketing Authorization Application (MAA) based on landmark global CAR-T clinical trials ELIANA and [...]

Arch Therapeutics, Inc. $4.5 Million Registered Direct Offering

29/06/2018 - 14:10

FRAMINGHAM, Mass., June 29, 2018 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB:ARTH) (“ Arch ” or the “ Company ”), a developer of innovative materials as hemostatic and wound care devices, today announced the [...]

The American Health Council Selects Sara Safder, MD to Board of Physicians

29/06/2018 - 14:00

NEW YORK, June 29, 2018 (GLOBE NEWSWIRE) -- Sara Safder, MD was recently selected to the American Health Council’s Board of Physicians for her outstanding contributions to the medical field. A radiologist at Lakeland [...]

BioSig Technologies to Present at the Emerging Medical Technologies Spotlight

29/06/2018 - 14:00

Santa Monica, CA, June 29, 2018 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical technology company developing a proprietary biomedical signal processing platform designed to address an unmet [...]

Tetra Bio-Pharma’s Evidence-Based Business Model Confirmed

29/06/2018 - 14:00

Tetra Bio-Pharma provides extension to North Bud Farms ORLEANS, Ontario, June 29, 2018 (GLOBE NEWSWIRE) -- Tetra Bio-Pharma Inc ., a leader in cannabinoid-based drug discovery and development (TSX VENTURE:TBP) (OTCQB: [...]

Samumed Announces Presentation of Clinical Data Analysis on SM04690 for Treatment of Knee Osteoarthritis at International Workshop on Osteoarthritis Imaging (IWOAI) 2018 Conference

29/06/2018 - 14:00

SAN DIEGO, June 29, 2018 (GLOBE NEWSWIRE) -- Samumed, LLC, announced today that it will present an analysis of phase 2 clinical data on SM04690 for the treatment of knee osteoarthritis (OA) as a poster at the [...]

ContraVir Pharmaceuticals Announces $10.8 Million in Expected Gross Proceeds from Recently Expired Rights Offering

29/06/2018 - 14:00

EDISON, N.J., June 29, 2018 (GLOBE NEWSWIRE) -- ContraVir Pharmaceuticals, Inc. (NASDAQ:CTRV) (“ContraVir” or the “Company”), a biopharmaceutical company focused on the development and commercialization of therapeutic [...]

Extendicare Announces Timing of 2018 Second Quarter Results and Conference Call

29/06/2018 - 14:00

MARKHAM, Ontario, June 29, 2018 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX:EXE) announced today that it plans to release its financial results for the second quarter of 2018, after market [...]

APEIRON, the Medical University of Vienna and the Institute of Molecular Biotechnology Sign Licensing Agreement for a New Checkpoint Inhibitor

29/06/2018 - 13:30

APEIRON strengthens its proprietary Cbl-b portfolio with cutting edge immunotherapy technology developed at IMBA VIENNA, Austria, June 29, 2018 (GLOBE NEWSWIRE) -- APEIRON Biologics AG, a company focused on cancer [...]

Change in number of shares and votes in Saniona AB (publ)

29/06/2018 - 13:15

PRESS RELEASE June 29, 2018 During June, the registered number of shares and votes in Saniona AB (publ) (“Saniona”) has increased due to conversion of convertible notes issued pursuant to the convertible notes funding [...]

Akers Biosciences Requests Temporary Suspension of Trading on London Stock Exchange

29/06/2018 - 13:00

THOROFARE, N.J., June 29, 2018 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (“Akers Bio” or the "Company"), a developer of rapid health information technologies, announces that the Company [...]

Dermira Receives FDA Approval for Qbrexza™ (glycopyrronium) Cloth to Treat Primary Axillary Hyperhidrosis

29/06/2018 - 13:00

Qbrexza is the first FDA-approved, once-daily, topical prescription treatment indicated for people with primary axillary hyperhidrosis, also known as excessive underarm sweating The chronic, medical skin condition is [...]